The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart: A New Era in the Treatment of Heart Failure
Abstract
Abstract Myocardial failure has been considered to be an irreversible and progressive process characterized by ventricular enlargement, chamber geometric alterations, and diminished pump performance. However, more recent evidence has suggested that certain types of medical therapy may lead to retardation and even reversal of the cardiomyopathic process. In the failing heart, long-term neurohormonal/autocrine-paracrine activation results in abnormalities in myocyte growth, energy production and utilization, calcium flux, and receptor regulation that produce a progressively dysfunctional, mechanically inefficient heart. Interventions such as ACE inhibition and β-blockade result in a reduction in the harmful long-term consequences of neurohormonal/autocrine-paracrine effects and retard the progression of left ventricular dysfunction or ventricular remodeling. Furthermore, in subjects with idiopathic dilated or ischemic cardiomyopathy, antiadrenergic therapy with β-blocking agents appears to be able to partially reverse systolic dysfunction and ventricular remodeling. Although the precise mechanisms underlying this latter effect have not yet been elucidated, the general mechanism appears to be via improvement in the biological function of the cardiac myocyte. Such an improvement in the intrinsic defect(s) responsible for myocardial failure will likely translate into important clinical benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Self-citationSwedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Wall stress and patterns of hypertrophy in the human left ventricle.
Grossman, W., Jones, D., & McLaurin, L. P. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108079 · Cited by 2,403
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Self-citationEffect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Cited by
Jessup, M., & Brozena, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021498 · Cited by 1,564
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303
Self-citationβ-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
Self-citationMechanisms and Models in Heart Failure: The Biomechanical Model and Beyond
Mann, D. L., & Bristow, M. R. (2005) · Circulation · doi:10.1161/circulationaha.104.500546 · Cited by 867
Self-citationChronic Heart Failure in the United States: A Manifestation of Coronary Artery Disease
Gheorghiade, M., & Bonow, R. O. (1998) · Circulation · doi:10.1161/01.cir.97.3.282 · Cited by 787
Mechanisms and Models in Heart Failure: A Combinatorial Approach
Mann, D. L. (1999) · Circulation · doi:10.1161/01.cir.100.9.999 · Cited by 773
Communal, C., Singh, K., Pimentel, D. R., & Colucci, W. S. (1998) · Circulation · doi:10.1161/01.cir.98.13.1329 · Cited by 690
Yazaki, Y., Isobe, M., Hiroe, M., Morimoto, S.-I., Hiramitsu, S., Nakano, T., Izumi, T., & Sekiguchi, M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01978-6 · Cited by 664
Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F. D., Dal Bello, B., Semigran, M. J., Bielsa-Masdeu, A., Dec, G. W., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8144 · Cited by 585
Myocardial Gene Expression in Dilated Cardiomyopathy Treated with Beta-Blocking Agents
Lowes, B. D., Gilbert, E. M., Abraham, W. T., Minobe, W. A., Larrabee, P., Ferguson, D., Wolfel, E. E., Lindenfeld, J., Tsvetkova, T., Robertson, A. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012630 · Cited by 501
Self-citationZhu, W.-Z., Zheng, M., Koch, W. J., Lefkowitz, R. J., Kobilka, B. K., & Xiao, R.-P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1607 · Cited by 464
Congestive Heart Failure: Fifty Years of Progress
Braunwald, E., & Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_4.iv-14 · Cited by 437
Self-citationAnimal Models of Heart Failure: A Scientific Statement From the American Heart Association
Houser, S. R., Margulies, K. B., Murphy, A. M., Spinale, F. G., Francis, G. S., Prabhu, S. D., Rockman, H. A., Kass, D. A., Molkentin, J. D., Sussman, M. A., et al. (2012) · Circulation Research · doi:10.1161/res.0b013e3182582523 · Cited by 435
Return to the fetal gene program protects the stressed heart: a strong hypothesis
Rajabi, M., Kassiotis, C., Razeghi, P., & Taegtmeyer, H. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9034-1 · Cited by 426
Return to the fetal gene program: A suggested metabolic link to gene expression in the heart
Taegtmeyer, H., Sen, S., & Vela, D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05100.x · Cited by 411
Bell, D. S. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2433 · Cited by 404
Mutations in Ribonucleic Acid Binding Protein Gene Cause Familial Dilated Cardiomyopathy
Brauch, K. M., Karst, M. L., Herron, K. J., de Andrade, M., Pellikka, P. A., Rodeheffer, R. J., Michels, V. V., & Olson, T. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.038 · Cited by 368
Udelson, J. E., Smith, W. B., Hendrix, G. H., Painchaud, C. A., Ghazzi, M., Thomas, I., Ghali, J. K., Selaru, P., Chanoine, F., Pressler, M. L., et al. (2001) · Circulation · doi:10.1161/hc4501.099313 · Cited by 362
Cardiac autonomic neuropathy in patients with diabetes mellitus
Dimitropoulos, G. (2014) · World J Diabetes · doi:10.4239/wjd.v5.i1.17 · Cited by 357
Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
de Man, F. S., Tu, L., Handoko, M. L., Rain, S., Ruiter, G., François, C., Schalij, I., Dorfmüller, P., Simonneau, G., Fadel, E., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0411oc · Cited by 346
Heart Failure Society Of America (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)91340-4 · Cited by 336
Bello, D., Shah, D. J., Farah, G. M., Di Luzio, S., Parker, M., Johnson, M. R., Cotts, W. G., Klocke, F. J., Bonow, R. O., Judd, R. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095029.57483.60 · Cited by 336
Lowes, B. D., Gill, E. A., Abraham, W. T., Larrain, J.-R., Robertson, A. D., Bristow, M. R., & Gilbert, E. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00059-4 · Cited by 318
Self-citation(1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00246-5 · Cited by 280
Altered Beta-adrenergic Receptor Gene Regulation and Signaling in Chronic Heart Failure
Port, J. D., & Bristow, M. R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1358 · Cited by 280
Self-citationPotassium channel down-regulation in heart failure
Näbauer, M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00274-5 · Cited by 271
Xiao, R.-P. (2001) · Science's STKE · doi:10.1126/stke.2001.104.re15 · Cited by 264
Choi, D.-J., Koch, W. J., Hunter, J. J., & Rockman, H. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17223 · Cited by 261
Mechanism of Action of Beta-Blocking Agents in Heart Failure
Bristow, M. R. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00846-1 · Cited by 259
Self-citationEffect of cardiac sympathetic nervous activity on mode of death in congestive heart failure
Brunner-La Rocca, H. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2407 · Cited by 224
Erland, E., Philippe, L., Patricia, V., & Hermann, W. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00174-x · Cited by 190
Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression
Du Bois, P., Pablo Tortola, C., Lodka, D., Kny, M., Schmidt, F., Song, K., Schmidt, S., Bassel-Duby, R., Olson, E. N., & Fielitz, J. (2015) · Circulation Research · doi:10.1161/circresaha.114.305393 · Cited by 92
de Tombe, P. P., & Solaro, R. J. (2000) · Annals of Biomedical Engineering · doi:10.1114/1.1312189 · Cited by 61
Metadata
- Authors
- Eichhorn, E. J., & Bristow, M. R.
- Venue
- Circulation
- Published
- 1996-11
- Volume
- 94
- Issue
- 9
- Pages
- 2285-2296
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2021315555
- Cited by
- 468
- References
- 127
- FWCI
- 24.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.